Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

Total article views   HTML views PDF downloads Totals
8,547 Dovepress* 7,423+ 1,627 9,050
PubMed Central* 1,124 358 1,482
Totals 8,547 1,985 10,532
*Since 4 July 2019

View citations on PubMed Central and Google Scholar